CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 26  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0949
LYS 10.0949
GLU 20.0614
LEU 30.0296
ARG 40.0160
CYS 50.0183
GLN 60.0182
CYS 70.0236
ILE 80.0526
LYS 90.0470
THR 100.0174
TYR 110.0130
SER 120.0153
LYS 130.0280
PRO 140.0124
PHE 150.0104
HIS 160.0030
PRO 170.0050
LYS 180.0100
PHE 190.0089
ILE 200.0068
LYS 210.0120
GLU 220.0086
LEU 230.0047
ARG 240.0095
VAL 250.0120
ILE 260.0176
GLU 270.0292
SER 280.0272
GLY 290.0339
PRO 300.0445
HIS 310.0083
CYS 320.0155
ALA 330.0224
ASN 340.0189
THR 350.0160
GLU 360.0136
ILE 370.0077
ILE 380.0088
VAL 390.0078
LYS 400.0097
LEU 410.0074
SER 420.0176
ASP 430.0264
GLY 440.0205
ARG 450.0111
GLU 460.0131
LEU 470.0110
CYS 480.0110
LEU 490.0102
ASP 500.0077
PRO 510.0025
LYS 520.0153
GLU 530.0166
ASN 540.0260
TRP 550.0147
VAL 560.0110
GLN 570.0090
ARG 580.0107
VAL 590.0089
VAL 600.0056
GLU 610.0054
LYS 620.0055
PHE 630.0054
LEU 640.0045
LYS 650.0025
ARG 660.0050
ALA 670.0060
GLU 680.0071
ASN 690.0186

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.